Logo for Vericel Corporation

Vericel Investor Relations Material

Latest events

Logo for Vericel Corporation

Q3 2024

Vericel
Logo for Vericel

Q3 2024

7 Nov, 2024
Logo for Vericel

Q2 2024

1 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Vericel Corporation

Access all reports
Vericel Corporation is a commercial-stage biopharmaceutical company that engages in the research, development, manufacture and distribution of cellular therapies for sports medicine and severe burn care markets. The company has two product candidates: Carticel, its autologous cultured chondrocytes product for the treatment of articular cartilage defects due to degenerative joint diseases; and AlloCello, its ex vivo expanded allogeneic progenitor cells product for the treatment of critical limb ischemia. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.